Open Access
Volume 5, 2019
Article Number 10
Number of page(s) 6
Section Spine
Published online 01 April 2019
  1. Burch S, Hu S, Berven S (2008) Aneurysmal bone cysts of the spine. Neurosurg Clin N Am 19, 41–47. [CrossRef] [PubMed] [Google Scholar]
  2. Boriani S, De Iure F, Campanacci L, et al. (2001) Aneurysmal bone cyst of the mobile spine: report on 41 cases. Spine 26, 27–35. [CrossRef] [PubMed] [Google Scholar]
  3. Leithner A, Windhager R, Lang S, et al. (1999) Aneurysmal bone cyst. A population based epidemiologic study and literature review. Clin Orthop Relat Res 363, 176–179. [Google Scholar]
  4. Zileli M, Isik HS, Ogut FE, et al. (2013) Aneurysmal bone cysts of the spine. Eur Spine J 22, 593–601. [CrossRef] [PubMed] [Google Scholar]
  5. Lim JB, Sharma H, Reid R, et al. (2012) Aneurysmal bone cysts of the vertebrae. J Orthop Surg (Hong Kong) 20, 201–204. [CrossRef] [PubMed] [Google Scholar]
  6. Lange T, Stehling C, Frohlich B, et al. (2013) Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts. Eur Spine J 22, 1417–1422. [CrossRef] [PubMed] [Google Scholar]
  7. Lau AW, Pringle LM, Quick L, et al. (2010) TRE17 (ubiquitin-specific protease 6 (USP6) oncogene translocated in aneurysmal bone cyst blocks osteoblastic maturation via an autocrine mechanism involving bone morphogenetic protein dysregulation. J Biol Chem 285, 37111–37120. [PubMed] [Google Scholar]
  8. Oliveira AM, Chou MM, Perez-Atayde AR, Rosenberg AE (2006) Aneurysmal bone cyst: a neoplasm driven by upregulation of the USP6 oncogene. J Clin Oncol 24(1), e1. [CrossRef] [PubMed] [Google Scholar]
  9. Chawla S, Henshaw R, Seeger L, et al. (2013) Safety and efficacy of Denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel group, phase 2 study. Lancet Oncol 14, 901–908. [CrossRef] [PubMed] [Google Scholar]
  10. Martin-Broto J, Cleeland CS, Glare PA, et al. (2014) Effects of Denosumab on pain and analgesic use in giant cell tumour of bone: interim results from a phase II study. Acta Oncol 53, 1173–1179. [CrossRef] [PubMed] [Google Scholar]
  11. Skubitz KM (2014) Giant cell tumour of bone: current treatment options. Curr Treat Options Oncol 15, 507–518. [CrossRef] [PubMed] [Google Scholar]
  12. Taylor RM, Kashima TG, Hemingway FK, et al. (2012) CD14- mononuclear stromal cells support (CD14R) monocyte-osteoclast differentiation in aneurysmal bone cyst. Lab Invest 92, 600–605. [PubMed] [Google Scholar]
  13. Skubitz Keith M, Peltola Justin C, Santos Edward R, et al. (2015) Response of aneurysmal bone cyst to denosumab. Spine 40(22), E1201–E1204. [CrossRef] [PubMed] [Google Scholar]
  14. Ghermandi R, Terzi S, Gasbarrini A, Boriani S (2016) Denosumab: non-surgical treatment option for selective arterial embolization resistant aneurysmal bone cyst of the spine and sacrum. Case report. Eur Rev Med Pharmacol Sci 20, 3692–3695. [PubMed] [Google Scholar]
  15. Dubory Arnaud, Missenard Gilles, Domont Julien, et al. (2016) Interest of Denosumab for the treatment of giant-cells tumors and aneurysmal bone cysts of the spine. About nine cases. Spine 41(11), E654–E660. [CrossRef] [PubMed] [Google Scholar]
  16. Pauli C, Fuchs B, Pfirrmann C, et al. (2014) Response of an aggressive periosteal aneurysmal bone cyst (ABC) of the radius to Denosumab therapy. World J Surg Oncol 12, 17. [CrossRef] [PubMed] [Google Scholar]
  17. Pelle DW, Ringler JW, Peacock JD, et al. (2014) Targeting receptor activator of nuclear kappa ligand in aneurysmal bone cysts: verification of target and therapeutic response. Transl Res 164, 139–148. [Google Scholar]
  18. Henry DH, Costa L, Goldwasser F, et al. (2011) Randomized, double-blind study of Denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. J Clin Oncol 29, 1125–1132. [CrossRef] [PubMed] [Google Scholar]
  19. Smith MR, Saad F, Coleman R, et al. (2012) Denosumab and bone metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial. Lancet 379, 39–46. [CrossRef] [PubMed] [Google Scholar]
  20. Stopeck AT, Lipton A, Body JJ, et al. (2010) Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. J Clin Oncol 28, 5132–5139. [CrossRef] [PubMed] [Google Scholar]
  21. Karras NA, Polgreen LE, Ogilvie C, et al. (2013) Denosumab treatment of metastatic giant-cell tumour of bone in a 10-year-old girl. J Clin Oncol 31, e200–e202. [CrossRef] [PubMed] [Google Scholar]
  22. Whyte MP, Wenkert D, Clements KL, et al. (2003) Bisphosphonate induced osteopetrosis. N Engl J Med 349, 457–463. [CrossRef] [PubMed] [Google Scholar]
  23. Kobayashi E, Setsu N (2015) Osteosclerosis induced by Denosumab. Lancet 385, 539. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.